(Drug Dev Ind Pharm[TA])
4,619 results
  • In vitro release kinetics and mathematical modeling of ribes nigrum extract-loaded PLGA/chitosan nanoparticles. [Journal Article]
    Drug Dev Ind Pharm. 2026 Oct 10; :1-16. [Online ahead of print]Karaduman E, Uygunoz D, … Moroydor Derun EDD
  • CONCLUSIONS: These findings demonstrate the value of comprehensive kinetic modeling in the design of nanoparticulate delivery systems and indicate that RN-loaded hybrid polymeric nanoparticles may be promising candidates for sustained-release mucosal delivery platforms. Further biological, stability, and in vivo studies are required to evaluate their therapeutic relevance and safety under physiologically relevant conditions.
  • Influence of infill pattern on ketoprofen release rate from 3D printed buccal films. [Journal Article]
    Drug Dev Ind Pharm. 2026 Oct 03; :1-14. [Online ahead of print]Čanji Panić J, Todorović N, … Lalić-Popović MDD
  • CONCLUSIONS: Combining filament soaking with FDM 3D printing enables fabrication of ketoprofen buccal films with sustained release. Simple infill pattern modifications effectively modulate release profiles, highlighting the potential of this accessible approach for personalized buccal drug delivery.
  • Design buccal film for systemic delivery of insulin. [Review]
    Drug Dev Ind Pharm. 2026 Oct 05; :1-24. [Online ahead of print]Esmaeili A, Dorkoosh F, Rafieian FDD
  • CONCLUSIONS: Mucoadhesive buccal films are a promising alternative for insulin administration. Future progress will likely depend on smart, stimuli-responsive formulations, especially glucose-responsive systems, and precision manufacturing approaches such as 3D printing. Clinical translation will require improved stability, permeability, standardization, and scalable production.